Settlements, News, Class Actions, Defective Products Volkswagen & Audi 2.0-Liter Emissions Settlement Provides Nearly $15 Billion For Affected Consumers And Environmental Remediation June 29, 2016 A proposed settlement of the Volkswagen “Clean Diesel” Marketing, Sales Practices, and Products Liability Litigation has been filed in the Northern District of California, where the federal multidistrict litigation is currently being overseen by Judge Charles M. Breyer. If approved, the settlement will ensure Volkswagen and Audi 2.0-liter TDI owners and lessees receive compensation and that remediation for the environmental impact of the excessive emissions will occur. If approved, the proposed settlement will be the largest consumer auto industry class action settlement in U.S. history, providing more than $10 billion for affected consumers and an additional $4.7 billion to remediate environmental damage caused by the vehicles. It’s been nearly a year since the United States Environmental Protection Agency issued a Notice of Violation of the Clean Air Act to Volkswagen AG, Audi AG, and Volkswagen Group of America, Inc., in September, alleging four-cylinder VW and Audi diesel cars with model years 2009 – 2015 were equipped with computer software in their “Clean Diesel” cars to circumvent EPA emissions standards for air pollution. The EPA called it a “defeat device,” and an enforcement investigation was initiated. During this time, a dedicated team of plaintiffs’ attorneys from firms all over the country, including Seeger Weiss partners Chris Seeger, Dave Buchanan, and TerriAnne Benedetto. Chris Seeger, who sat on the Plaintiffs’ Steering Committee, helped negotiate this historic settlement. Under the proposed agreement, owners of Volkswagen and Audi vehicles affected will be given the option of a buyback or lease termination, or an emissions modification that ensures the vehicle no longer generates excess nitrogen oxide emissions. The settlement will affect approximately 475,000 vehicles. Volkswagen will also pay $2.7 billion into a mitigation trust fund for environmental remediation and another $2 billion to promote Zero Emissions Vehicle technology. Additionally, the company is required to pay money into a mitigation trust if it fails to remove or modify at least 85% of the affected vehicles by the end of June 2019. The terms of the proposed class settlement are summarized as follows: Vehicle Buyback is available to eligible class members. If they choose this option, they will receive a payment equal to the September 2015 National Automobile Dealers Association (“NADA”) Clean Trade-In value of their vehicle, adjusted for their options and mileage. Certain owners will be eligible for loan forgiveness, and certain lessees will have the option of terminating their lease without penalty. Buybacks can begin as early as fall 2016. Owners and lessees who choose the Vehicle Fix option can wait to see if an emissions modification is approved by the EPA and CARB, and if so, can modify their non-compliant vehicle free of charge. They will also receive extended warranties and “lemon law” protections. If the modification is not approved, lessees and owners can participate in the Buyback Program or withdraw from the settlement. In addition to participation in the Buyback or Vehicle Fix Programs, class members will also receive cash payments based on a formula outlined in the settlement agreement. Most payments will range from $5100 to $10,000 per vehicle. To learn more about the settlement or to determine if you have an eligible vehicle, visit VWCourtSettlement.com. If the Court grants preliminary approval of the settlement on July 26, 2016, the site will feature a secure settlement look-up tool that can help you determine, based on your vehicle’s VIN number, whether you are eligible. When and if the settlement receives final approval, the claims process will open to all Volkswagen and Audi 2.0-liter owners and lessees without delays on appeal. **We are no longer accepting cases.** Recent News November 05, 2021 Seeger Weiss’s Inaugural Diversity Fellow Brittany Jackson Designates San Francisco’s 100% College Prep for Charitable Contribution Read More September 13, 2021 Chris Seeger Appointed Interim Co-Lead Counsel in Key Safety Systems Litigation Read More July 21, 2021 Plaintiffs’ Executive Committee Unanimously Endorses $26 Billion Global Opioid Settlement and Strongly Encourages Participation Across the Country as Nationwide Litigation Continues Read More June 21, 2021 Jury awards Iraq veteran $1.7 million in crucial 3M bellwether trial Read More April 05, 2021 Seeger Weiss welcomes seasoned litigator Jacksy Bilsborrow as newest partner Read More April 02, 2021 Matt Pawa named to inaugural Lawdragon “Environmental and Energy Lawyers” guide Read More FREE CASE EVALUATION Since its establishment in 1999, Seeger Weiss has led some of the most complex and high-profile litigations in the U.S. With offices in New York, New Jersey, Pennsylvania, and Massachusetts, our firm is primarily known for multidistrict mass torts and class actions in both state and federal courts, with a strong track record of landmark verdicts and settlements. Sign up to our Newsletter Subscribe Now Main Navigation Home Investigations Results News About Us Contact Us Practice Areas Antitrust Consumer Protection & Class Actions Drug Injury Lawsuits Whistleblower Lawsuits Sex Abuse Survivor Claims Securities Litigation Serious Bodily Injury Defective Medical Devices Environmental & Toxic Exposure Lawsuits General & Commercial Litigation Quick Connect 55 Challenger Road 6th Floor, Ridgefield Park, NJ 07660 intake@seegerweiss.com Home About Us Investigations Results News Contact Us Disclaimer Privacy Policy NOTICE: This website, the related links, and the social media accounts of Seeger Weiss contain Attorney Advertising. No aspect of this or any advertisement has been approved by the Supreme Court of New Jersey. Seeger Weiss’ websites and social media accounts are designed for general information only. The information contained on Seeger Weiss’ websites and social media accounts should not be construed as legal advice, should not be relied upon as a substitute for the retention of an attorney or for independent legal research, and does not create an attorney-client relationship. The materials presented by this website are not medical advice, and are not a substitute for the opinion of a qualified healthcare professional. Do not stop taking a prescribed medication without first consulting with your doctor. Discontinuing a prescribed medication without your doctor’s advice can result in injury or death. An endorsement of the firm or report of prior results does not guarantee or predict a similar outcome with respect to any future matter. © 2021 - Seeger Weiss | All Rights Reserved.